ARID3B, standing for AT-Rich Interaction Domain 3B, is a protein encoded by the ARID3B gene in humans. This protein is a member of the ARID (AT-rich interaction domain) family of DNA-binding proteins, which are known for their involvement in cell growth, differentiation, and development. ARID3B, like other family members, is characterized by having a specific type of DNA-binding domain that interacts preferentially with AT-rich regions in DNA.The ARID3B protein plays a crucial role in the regulation of gene expression. It functions as a transcription factor, binding to specific DNA sequences to regulate the transcription of target genes. This regulation is essential for various developmental processes, including the differentiation and maturation of cells, particularly in embryonic development.
In addition to its role in normal development, ARID3B has been implicated in cancer biology. It is believed to contribute to the pathogenesis of certain types of cancers through its influence on gene expression. For instance, overexpression of ARID3B has been observed in some forms of cancer, suggesting a role in tumor development or progression.Moreover, studies have suggested that ARID3B may be involved in the regulation of apoptosis, the programmed cell death process essential for maintaining cellular homeostasis and development. Dysregulation of apoptosis is a hallmark of cancer, and ARID3B's role in this process further underscores its relevance in oncology.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid, a metabolite of Vitamin A, regulates gene expression and is involved in cellular differentiation, which could influence ARID3B expression. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Vorinostat, another histone deacetylase inhibitor, can alter chromatin dynamics and gene expression, potentially impacting ARID3B. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium butyrate, as a histone deacetylase inhibitor, may affect gene expression in a manner that impacts ARID3B's role. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
Valproic Acid, another histone deacetylase inhibitor, could affect ARID3B's function by altering gene expression and chromatin structure. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein, a tyrosine kinase inhibitor, can modulate several signaling pathways, potentially intersecting with those regulated by ARID3B. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $131.00 $515.00 | 2 | |
RG108, a DNA methyltransferase inhibitor, might affect gene expression patterns in a way that influences ARID3B activity. | ||||||
Histone Lysine Methyltransferase Inhibitor Inhibitor | 935693-62-2 (free base) | sc-202651 | 5 mg | $151.00 | 4 | |
BIX-01294, a G9a histone methyltransferase inhibitor, could alter chromatin states and gene expression patterns affecting ARID3B. | ||||||
Ademetionine | 29908-03-0 | sc-278677 sc-278677A | 100 mg 1 g | $184.00 $668.00 | 2 | |
S-Adenosylmethionine, involved in methylation processes, could indirectly impact ARID3B function through epigenetic modifications. | ||||||
Disulfiram | 97-77-8 | sc-205654 sc-205654A | 50 g 100 g | $53.00 $89.00 | 7 | |
Disulfiram can modulate the activity of various enzymes and may influence cellular pathways related to ARID3B's function. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $55.00 | 6 | |
Mithramycin A, known to bind DNA and affect transcription, might influence the genetic networks involving ARID3B. | ||||||